Cañales, Renelia .
HRN: 01-62-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
CEFTAZIDIME 1GM (VIAL)
07/21/2023
07/28/2023
IV
1g
Q8H
CAP MR; S/P PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes